Mixed-effects models for longitudinal data compared the efficacy of PATH with that of ST-CI in reducing depression ( Montgomery-Asberg Depression Rating Scale ) and disability ( World Health Organization Disability Assessment Schedule II ) during 12 weeks of treatment .